within the swiftly evolving industry of oncology investigate, exact and effective mutation screening is essential for acquiring focused therapies. The KRAS Services Platform performs a pivotal role On this landscape by giving in depth solutions for KRAS mutation profiling and Investigation. KRAS mutations, present in roughly ninety five% of RAS-rel